Ipca Laboratories Financials

NSE: IPCALAB | BSE: 524494

₹1,987.60

₹12.70 (0.64%)

As on 01-Sep-2026IST

Market cap

₹50,384 Cr

Revenue (TTM)

₹10,126 Cr

P/E Ratio

38.5

P/B Ratio

5.9

Div. Yield

0.3 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	--	--	--	--	--	--
Total Income	--	--	--	--	--	--
Total Expenditure	--	--	--	--	--	--
EBITDA	--	--	--	--	--	--
Depreciation	--	--	--	--	--	--
EBIT	--	--	--	--	--	--
Interest	--	--	--	--	--	--
Other Income	--	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	--	--	--	--	--	--
Provision for Tax	--	--	--	--	--	--
Profit after Tax	--	--	--	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	--	--	--	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	--	--	--	--	--	--
Total Liabilities	--	--	--	--	--	--

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	5,384.61	5,972.79	5,475.09	5,558.15	3,433.59	3,164.34
Current Assets	6,373.61	6,373.61	5,967.04	5,535.55	5,189.27	4,446.71
Total Assets	12,370.19	12,349.65	11,743.63	11,097.05	8,622.86	7,621.51
Total Debt*	--	703.94	1,301.70	1,387.50	1,457.53	791.24
Net Current Assets	4,066.68	4,066.68	3,582.75	3,179.91	3,383.45	2,980.83
Contingent Liabilities	--	249.19	234.86	119.12	93.44	69.67

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	--	--	--	--	--
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	--	--	--	--	--	--
Cash EPS (₹)	--	--	--	--	--	--
Adjusted Book Value (₹)	--	--	--	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	--	--	--	--	--
Free Cash Flow per Share (₹)	--	--	--	--	--	--

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	--	--	--	--	--
ROE (%)	--	--	--	--	--	--
ROA (%)	--	--	--	--	--	--
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	--	--	--	--
Net Profit Growth (%)	--	--	--	--	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	--	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	--	--	--	--	--	--
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)